Literature DB >> 2482230

Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.

P B Belt1, H Groeneveld, W J Teubel, P van de Putte, C Backendorf.   

Abstract

A cDNA expression vector containing the element oriP and the sequence encoding the Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1) as well as the hygromycin B-resistance dominant marker gene has been constructed. Its characteristics have been compared to a similar vector lacking the EBV sequences. (a) The EBV+ vector is maintained as an episome with a copy number of approx. 50 per cell, whereas the number of the integrated EBV- copies is in general smaller than 10, when simian virus 40-transformed xeroderma pigmentosum fibroblasts (XP20S-SV) constitute the recipient cell line. (b) The presence of the EBV sequences in the vector resulted in a five- to ten-fold higher transfection efficiency with the Ca.phosphate precipitation technique. (c) cDNA inserts in the EBV+ vector are shown to be efficiently and properly expressed in the recipient cell. (d) If transfection is performed with a mixture of EBV+ vectors with different inserts, transfectants are shown to harbour different plasmids within one cell. (e) The ratio between these plasmids in one cell can be shifted in favour of a vector with a particular insert, when selection for this insert is performed. (f) Reconstruction experiments indicated that isolation of a low-abundance sequence from a mixture of vectors is at least 100-fold more efficient with the EBV+ system, than with the EBV- system. (g) Rescue of the episomal vector from transfected cells can be readily achieved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482230     DOI: 10.1016/0378-1119(89)90515-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  20 in total

1.  Induction of a mutant phenotype in human repair proficient cells after overexpression of a mutated human DNA repair gene.

Authors:  P B Belt; M F van Oosterwijk; H Odijk; J H Hoeijmakers; C Backendorf
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

2.  Characterization of the human spr2 promoter: induction after UV irradiation or TPA treatment and regulation during differentiation of cultured primary keratinocytes.

Authors:  S Gibbs; F Lohman; W Teubel; P van de Putte; C Backendorf
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

3.  DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines.

Authors:  C Trucco; F J Oliver; G de Murcia; J Ménissier-de Murcia
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

4.  Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.

Authors:  A Bossers; G J Raymond; B Caughey; R de Vries; M A Smits
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Epstein-Barr virus replication studies and their application to vector design.

Authors:  P M Brickell; M S Patel
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

6.  Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation.

Authors:  D F Fischer; S Gibbs; P van De Putte; C Backendorf
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.

Authors:  J A Gäken; M Tavassoli; S U Gan; S Vallian; I Giddings; D C Darling; J Galea-Lauri; M G Thomas; H Abedi; V Schreiber; J Ménissier-de Murcia; M K Collins; S Shall; F Farzaneh
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts.

Authors:  M S Meyn; J M Lu-Kuo; L B Herzing
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

9.  Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT-) using an Epstein-Barr virus-derived cDNA expression vector.

Authors:  P B Belt; W Jongmans; J de Wit; J H Hoeijmakers; P van de Putte; C Backendorf
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

10.  Transcriptional signature and memory retention of human-induced pluripotent stem cells.

Authors:  Maria C N Marchetto; Gene W Yeo; Osamu Kainohana; Martin Marsala; Fred H Gage; Alysson R Muotri
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.